La L-Carnitina es ampliamente conocida en deportistas y atletas de alto rendimiento debido a la mejora de la utilizacin de las grasas como forma de energa durante el ejercicio, ya que se ha demostrado que se aumenta el potencial de las mitocondrias mejorando la quema de grasa
CheckMate 238 (NCT02388906) compared nivolumab with ipi10 and found that nivolumab produced superior RFS and had a more tolerable safety profile.[20] Pembrolizumab produced superior RFS compared with placebo, with data on OS still maturing in the MK-3475-054/KEYNOTE-054 trial (NCT02362594).[21] Dabrafenib plus trametinib produced superior RFS compared with placebo, with data on OS still maturing in the COMBI-AD trial (NCT01682083).[22] Single-agent BRAF-inhibitor therapy with vemurafenib did not show improved RFS compared with placebo in the BRIM8 trial (NCT01667419).[23] The benefit of immunotherapy with ipilimumab, nivolumab, and pembrolizumab has been seen regardless of programmed death-ligand 1 (PD-L1) expression or the presence of BRAF pathogenic variants
- normal energy metabolism
SD: Validation, Writing review & editing, Writing - original draft
When it comes to peptide therapy, how you handle your medication at home matters just as much as the treatment itself
Is glutathione supplementation effective in treating rheumatoid arthritis?
